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Abstract
Various genomic islands, PAPI-1, PAPI-2, PAGI-1, PAGI-2, PAGI-3, and PAGI-4, and the element pKLC102 have been
characterized in different P. aeruginosa strains from diverse habitats and geographical locations. Chromosomal DNA
macroarray of 100 P. aeruginosa strains isolated from 85 unrelated patients hospitalized in an intensive care unit was created
to assess the occurrence of these genomic islands (GEIs). The macroarray was then hybridized with labeled probes derived
from each genomic island. In addition, PFGE patterns with SpeI, frequency of virulence genes, and antimicrobial resistance
patterns of the strains were studied. Our results showed that almost all P. aeruginosa strains presented up to eight virulence
genes. By SpeI macrorestriction fragment analysis we were able to identify 49 restriction patterns; 35 patterns correspond to
single strains and the remaining 14 to strains subgroup (a–n). Most of the strains showed variation in number or
composition of GEIs and a specific antimicrobial pattern indicating that each strain was an unrelated isolate. In terms of the
number of genomic islands per strain, 7 GEIs were found in 34% of the strains, 6 in 18%, 5 in 12%, 4 in 14%, 3 in 10%, 2 in
7%, and 1 in 4%; only one isolate did not present any GEI. The genomic islands PAPI-1 and PAPI-2 and the element pKLC102
were the most frequently detected. The analysis of the location of each GEI in the chromosome of two strains show that the
islands PAGI-3, PAPI-1, PAPI-2 and pKLC102 are present in the insertion site previously reported, but that PAGI-2 and PAGI-4
are inserted in another chromosome place in a site not characterized yet. In conclusion our data show that P. aeruginosa
strains exhibited an epidemic population structure with horizontal transfer of DNA resulting in a high frequency of GEIs.
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Introduction
Pseudomonas aeruginosa is a gram-negative rod bacterium, which is
reported to be ubiquitous in the natural environment, humans,
and animals, and is an important opportunistic human pathogen
that causes severe infections in immunocompromised patients [1–
4]. It has been commonly associated with repeated or persistent
bronchial infections in patients suffering from cystic fibrosis (CF),
and it is a major cause of nosocomial infections, mainly in
intensive-care units [5–7]. Many nosocomial infections are difficult
to eradicate due to a number of factors, the most important of
which is the relatively poor efficacy of antibiotics against P.
aeruginosa due to multiple resistance mechanisms expressed by the
bacterium [1,2]. Several cell-associated and secreted virulence
factors related to the bacterium have been described, which are
encoded on plasmids or chromosomal genes, such as lasB
(encoding for elastase), toxA (exotoxin-A), pilA (type fimbrial
precursor type IV pilin), plcH (hemolytic phospholipase C
precursor), phzA1 (phenazine biosynthesis protein), toxR (transcrip-
tional regulator), and lecA (lectin) [8–14]. Its ability to thrive in
a broad range of environments is partially due to a large and
diverse genome [12,15–21]. The bacterium presents a picture of
a mosaic genome consisting of a conserved core component
interrupted in each strain by combinations of specific blocks of
genes. These strain-specific segments of the genome are found in
limited chromosomal locations, referred to as genomic islands
(GEIs), which are acquired by horizontal gene transfer (HGT).
Depending on the functions they encode and the advantage they
confer relative to the specific lifestyle of a bacterium, GEIs can be
called pathogenicity, symbiosis, fitness, metabolic, or resistance
islands [22–25]. Furthermore, the presence of identical genes in
the pathogenic and non-pathogenic variants of one species – for
example, in extraintestinal pathogenic and commensal Escherichia
coli – implies that some of these encoded functions contribute to
general adaptability, fitness and competitiveness, rather than to
particular virulence traits [26]. A large number of GEIs in the P.
aeruginosa chromosome have been described; however, these GEIs
are found in variable numbers in some strains and not in others
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several islands. The genomic island PAGI-1 was first identified in
a urinary tract infection isolate, the sequence analysis of which
revealed a length of 48,893-bp with 51 predicted open reading
frames (ORFs), and present in 85% of the studied clinical strains
[28]. The islands PAGI-2 and PAGI-3 were discovered in the
strains C and SG17M respectively; PAGI-2 has a length of
104,955-bp with 111ORFs, while PAGI-3 contains a portion of
strain-specific DNA sequence of 103,304-bp with 106 ORFs. In
both strains, C and SG17M, the genomic islands are partitioned
into two blocks. The cluster adjacent to the attL site consists of
genes that are specific to each strain, while the other cluster
predominantly contains hypothetical ORFs of which 47 are
mutual homologs in both genomic islands [29]. Pseudomonas
aeruginosa genomic islands PAPI-1 and PAPI-2 have been identified
in the genome of PA14, a highly virulent clinical isolate [15]. The
PAPI-1 island has a size of 107,899-bp with 115 predicted ORFs
and has a highly mosaic structure. Remarkably, more than 80% of
its DNA sequence is unique and shows no similarity to any
GenBank sequences. Conversely, the other ORFs-translated
sequence show homology to proteins from several bacterial
species. Significantly, many PAPI-1 ORFs also occur in several
P. aeruginosa cystic fibrosis isolates, and approximately 11 genes
are required for virulence in plants and animals [15,30,31]. PAPI-
2 occupies a DNA region of 10,722-bp and an organization of 15
predicted ORFs, half of which encode to hypothetical proteins of
unknown function [15]. pKLC102 is a 103,532-bp integrative and
conjugative element initially found in the P. aeruginosa clone C
strain SG17M that can exist as a plasmid or integrate into the
chromosome, and can excise from the chromosome at a rate of up
to 10%. This element revealed 105 coding sequences (CDS), 60 of
which were classified as hypothetical or of unknown origin. Many
of these hypothetical genes have DNA replication, recombination,
and modification genes as neighbors. Syntenic sets of homologous
genes were identified in other plasmids and genomic islands
among gram-negative bacteria, including PAGI-2 and PAGI-3 of
P. aeruginosa clone C strains [32,33]. The island PAGI-4 has
a length of 23.4-kb and is integrated at the 39 end of the tRNALys
gene of the strain C. The 9.5-kb segment adjacent to the tRNALys
gene is homologous not only with sequences of the chromosomal
and episomal versions of pKLC102 in strain C but also with the
tRNAGly-associated genomic island PAGI-2 [32]. Seven novel
genomic islands have been identified, PAGI-5 -6, -7, -8, -9, -10
and -11, with sizes varying from 99 to 2-kb and containing a total
of 201 ORFs among them. Several are related to known
pathogenicity islands, phages, or Rhs elements while others are
quite novel [34,35].
The aim of this study is the phenotypic and genetic
characterization of a large collection of Pseudomonas aeruginosa
strains, isolated mostly from patients with pneumonia at an
intensive-care unit (ICU) of a specialty hospital from Mexico City,
analyzing the frequency of several GEIs (PAPI-1, PAPI-2, PAGI-1,
PAGI-2, PAGI-3 and PAGI-4), an integrative element pKLC102
and of different virulence factors. To our knowledge, this is the first
report of the high prevalence in a single ICU of P. aeruginosa strains
with multiple GEIs.
Materials and Methods
Bacterial Strains
A collection of 100 clinical strains of P. aeruginosa were used in
this study. The clinical strains were isolated between January 2005
and November 2006 from 85 patients admitted to the intensive
care unit (ICU) of Hospital de Especialidades at Centro Medico
Nacional, Siglo XXI in Mexico City. 7 of 85 patients presented 2
different strain isolates on different dates, while other 4 patients
were infected with 3 different strains. Most of the patients were
diagnosed with ventilator-associated pneumonia, with the remain-
ing cases being diagnosed with septicemia and meningitis. The
clinical strains were obtained from different sources: 60 were
isolated from bronchial washings, 18 from sputum, 10 from blood,
2 from throat swabs, 2 from cerebrospinal fluid, 1 from pleural
fluid, and 7 from unknown origin. The reference strains used as
positive controls were P. aeruginosa PAO14 and P. aeruginosa
clone C strains: C and SG17M, which were provided by Dr. B.
Tu ¨mmler from Hannover, Germany. P. aeruginosa PAO1 was used
as a negative control. All the strains were maintained in 15%
glycerol at 270uC. Each strain was biochemically typed using
conventional biochemical tests and the API20 NE system. All
strains showed biochemical patterns of P. aeruginosa. The project
was approved by the Ethics Committee of the Hospital de
Especialidades of the Centro Medico Nacional, Instituto Mex-
icano del Seguro Social, and CIE (32-2007, Comisiones de
Investigacio ´n y E ´tica) Medicine School Universidad Nacional
Auto ´noma de Me ´xico. Mexico City, Mexico. In all cases patients
or relatives were informed about the nature of the study and were
asked to sign a consent form.
Virulence Genes Detection
Seven structural and virulence P. aeruginosa genes (toxA, lasB, lecA,
algR, plcH, phzA1 and toxR) were selected and amplified by PCR
with specific primers designed in the laboratory, the annealing
temperature of each primer pair is shown in Table 1. For pilA gene
detection, we designed a probe derived from the conserved region
corresponding to 59 end of pilA gene, it is located from nucleotides
5234035 to 5233992 with respect to strain UCBPP-PA14 and
from nucleotides 5069556 to 5069473 with respect to the strain
PAO1 (Table 1). Additionally, knowing the variability of pilA gene,
we completed its detection using a primer set proposed by Kus
et al. [36], which was designed to amplify from the conserved pilB
gene to the tRNA
Thr gene.
Probes Used for GEIs Detection
We amplified by PCR the specific genes ORF3, ORF18 and
ORF42 of PAGI-1; C22 and C105 of PAGI-2; and SG8 and
SG100 of PAGI-3; using the primer pairs described by Finnan
[37]. We amplified genes CP10, CP44 and CP97 of pLKC102
using the primer pairs described by Klockgether [33]. The selected
genes represent the left portion, right portion, and middle region
of each island. We used the primer sets proposed by Qiu [31] to
amplify different DNA segments of PAPI-1: the primer pair 976F
and PAPI-1R detected the integration of PAPI-1 at the attB site in
the locus PA0976; the primer pairs 4542F + intF and sojR +
4541F were used to amplify and detect the left and right junction
sequences between the chromosome and island respectively when
it is integrated into the chromosome at the attB site in the tRNA
Lys
gene locus PA4541.1 corresponding to the strain PA14, and finally
the primer pair intF + sojR was used to detect the presence of
a circular PAPI-1 (Table 1). We designed in the laboratory three
pairs of primers to amplify three specific regions of PAPI-2: the
primers PAPI-2-1F and PAPI-2-1R were used to amplify the xerC
gene localized at locus RS02 at the left region of PAPI-2; the
primers PAPI-2-2F and PAPI-2-2R were used to amplify the
middle region (locus RS07 and RS08) of the island, and the
primers PAPI-2-3F and PAPI-2-3R were used to amplify the exoU
gene (locus RS14) localized at the right region of the PAPI-2. We
designed a primer set to amplify the gene CL22, this gene was
chosen because it is a specific gene of PAGI-4 without significant
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PCR protocols to amplify each gene belonging to PAGI-1, PAGI-
2, PAGI-3, pKLC102 and PAPI-1 were done according to
authors’ instructions [31,33,37]. Thermal cycling condition for the
genes of PAPI-2 and PAGI-4 were: an initial denaturation cycle at
94uC for 2 min, followed by 35 cycles at 94uC for 1 min,
annealing temperature (according to each specific primer set
[Table 1]) for 1 min and 72uC for 1 min with a final cycle of 72uC
Table 1. Primer sequence used in the genetic characterization of P. aeruginosa clinical strains.
Gene/GEIs* Forward primer sequence (59–39) Reverse primer sequence (59–39)T m
Size of
PCR
product Reference
Virulence gene
toxA TCAGGGCGCACGAGAGCAACGAGA GACAGCCGCGCCGCCAGGTAGAGG 66.1uC 454pb This study
lasB ACTGTCGCGGCCGCATTTCGTCAT CATCGCCGTGCCGTCCCAGTAGG 65uC 433pb This study
lecA CGATGTCATTACCATCGTCG TGATTGCACCCTGGACATTA 65uC 215pb This study
algR AGGGCAACTGGACGGCTATC TGTGGTCGGCAATGAAGAAGA 63uC 437pb This study
plcH CGACGAGGGCGACGGCTTCTATGA CCGGGCAGGCTCTTGGGCTCGTA 66uC 447pb This study
phzA1 AACCACTTCTGGGTCGAGTG GTGGGAATACCGTCACGTTT 65uC 203pb This study
toxR ATGGCATCTATGCGAGGAAC GCAGGGGAATGAAGTTCTTG 65uC 207pb This study
pilA
pilB/tRNAThr
W TCCAGCAGCATCTTGTTGACGAA CGAATGAGCTGCTCTACCGACAGAGCT 55uC 1–4-kb Kus, 2004
pilA probe TGATCGAACTGATGATCGTGGTTGCGATCATCGG 58uC - This study
oprL
W AGGGCGGCGATGCTTCC CGACGCGACGGTTCTGAG 61.1uC 420pb This study
lipA
W CAAGCCGGGCAAGGTGGAAGTCG CGGATCTCGCGCAGGCAGTCG 65.1uC 456pb This study
PAGI-1
orf3 TGGTGCTGACCAGCGACAAG TCCATCGACTCGGTGCGTAG 60uC 958pb Finnan, 2004
orf18 ATTCCTCCACTGCCGTTCACAACG CCTTGCTCATCTGGAACAGGTAGC 60uC 1039pb Finnan, 2004
orf42 CGGAGAACCATCTCTCGCACAC GGCTAAGACGTTCGACTGATTCC 60uC 675pb Finnan, 2004
PAGI-2
c22 CCTTCGTCCATTACCTGTGGAAC AACTTGCGAGCCAACTCACG 62.4uC 943pb Finnan, 2004
c105 GATTGATGCTCAACGACGATGG GCTGTTCCGCCTTCAGTTCC 59uC 681pb Finnan, 2004
PAGI-3
sg8 TACAGAGTGCCCGAGCTGATG GTGCTTCCCTGAGAGACAGACG 62uC 732pb Finnan, 2004
sg100 GCAATCTGTACGTCCTGCACG AGCACGGCTTGTCGCTGTTC 62uC 553pb Finnan, 2004
PAGI-4
CL22 CATGATCCGGCACACTGAGGTC ATGATGGCGAGCGCTACAAGGTTC 60.6uC 464pb This study
PAPI-1
976F/PAPI-1R GCCTGACGGTGTCCTGTTAT GCTGCCTCTCCTACGAACA 58uC 2600pb Qiu 2006
4542F/intF GTGGTGATGACCTCCAACCT AGCTACATCGAGGCCGACTA 58uC 1600pb Qiu 2006
SojR/4541F CGAGCACAGAAATGTCCTGA GACAAGACCAGCCACAACCT 58uC 1600pb Qiu 2006
IntF/sojR AGCTACATCGAGGCCGACTA CGAGCACAGAAATGTCCTGA 58uC 1600pb Qiu 2006
pKLC102
cp10 CGGACCACTAGATAGCCAGG GGACGCCATTGAGTATGCGC 61uC 255pb Klockgether
2007
cp44 GGGTCCGCAAAACTTTCCGC GCTTGAGGTTGGGCCAATCG 61uC 272pb Klockgether
2007
cp97 GGATATCTACGTACCCCGGC CTTTTTACCCGCAGTGGCGG 61uC 337pb Klockgether
2007
PAPI-2
xerC
PAPI-2 1F/1R
TGTTCCGCTCGGGTGCCTTCATC CACGCATCACTCCCGCCTGGTTC 66uC 417pb This study
RS07-RS08
PAPI-2 2F/2R
GGCGAGGTCCAGAATGTGTCAGG TCCCCGCCCGCAGAGTCA 66uC 402pb This study
exoU
PAPI-2 3F/3R
GCGGCGCAACGACAACCTGAT GAAAAGCCACCGCCCCGTCTGT 66uC 434pb This study
*Genomic islands, W Marker gene for hypervariable region location.
doi:10.1371/journal.pone.0037459.t001
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which were labeled with DIG High Prime DNA labeling
according to the manufacturer’s instructions (Roche Applied
Science, Germany).
Chromosomal DNA Isolation and Macroarray printing
Chromosomal DNA was isolated from overnight cultures of
each of the 100 clinical P. aeruginosa strains analyzed in this work,
as well as the 4 P. aeruginosa reference strains, (PA14, PAO1, C and
SG17M). DNA was purified from bacteria by miniprep (DNeasy
Blood & Tissue Kit QIAGEN) as previously described, and
adjusted to 100 ng/ml. An aliquot of 40 ml of each DNA was
dispensed individually into a 384-well plate, denatured for 30 mins
at 65uC, and chilled on ice. Each DNA was spotted by duplication
onto nylon membranes by Virtek’s ChipWriter System robot.
Macroarray copies were produced in parallel from the same stock
of DNA to ensure that the corresponding spot was represented by
identical amounts of sample on each membrane.
Hybridization of Macroarray
Membranes were incubated for 3 hrs at 60uC with hybridiza-
tion buffer (Roche Diagnostics), and hybridized overnight at 60uC
using the same buffer with Dig-labeled PCR product (correspond-
ing to each selected gene). The membranes were washed twice for
30 min at 65uC in washing buffer (0.1 M maleic acid, 0.15 M
NaCl, pH 7.5, 0.3% (v/v) Tween 20). Detection of DIG-labeled
fragments and exposure to X-ray film were performed according
to manufacturer’s instructions. A presence/absence determination
was made by comparison with hybridization signals obtained with
reference strains.
Macrorestriction Analysis
Genomic DNA in agarose blocks was prepared using the
method previously described by Liu [38] with some modifications.
Briefly, bacteria were grown overnight (for no more than 15 hrs.)
in 5 ml of Luria-Bertani (LB) broth and harvested by centrifuga-
tion. The bacterial pellet was washed in 500 ml of cool PIV
(10 mM Tris [pH 8], 1 M NaCl). This procedure was repeated up
to 5 times, depending on the amount of alginates present in the
culture and adjusted to 5 OD at 600 nm. Then, 200 ml of the cell
suspension was mixed with an equal volume of 1.5% low melting
temperature agarose. The mixture was drawn into disposable plug
molds (BioRad) and cooled at 4uC. The agarose plugs were
incubated overnight at 37uC in 2 ml of lysis solution (1 M Tris
[pH 8], 1 M NaCl, 0.5 M EDTA [pH 8], 0.5% sodium deox-
icolate, 12.5% N-lauroyl-sarcosine, 5mg/ml RNAse, 10 mg/ml
lysozyme), then the blocks were incubated again overnight at 50uC
in ESP (10 mM Tris HCl [pH 7.4], 1 mM EDTA, 0.25% N-
lauroyl-sarcosine, 0.1 mg/ml proteinase K [Sigma]). A second
incubation in ESP solution was performed in order to increase the
purity of the DNA. Finally, blocks were washed 7 times (for 1 hr.
each) with cool TE solution (Tris-HCl 10 mM [pH 8], 1mM
EDTA [pH 8]) and stocked in TE buffer at 4uC. Agarose blocks
were pre-incubated in 1X buffer used for SpeI enzyme for 30 mins
at 37uC and then incubated with 100 ml of fresh 1X buffer
containing 30 U of SpeIa t3 7 uC overnight to digest DNA in the
blocks. SpeI fragments were separated by a CHEF-DR II device
(Bio-Rad) and electrophoresis was performed on 1.2% agarose gels
and 0.5X TBE buffer at 10uC with pulse time ramped from 5 to
25 s over 19 hrs and 5.3 V/cm and a second block with pulse time
ramped from 5 to 60 s over 17 hrs and 5.3 V/cm. Sizes of SpeI
fragments were estimated using XbaI fragments of Salmonella
braenderup global standard H9812. Gels were stained with ethidium
bromide, photographed and then analyzed using whole band
analyzer software (Bioimage). To determine similarity of SpeI
fingerprints, a presence/absence band matrix was constructed and
then a dendrogram was generated by the Neighbor-joining
method using Nei’s minimum distance (1972). The algorithms
were implemented in Tools for Population Genetic Analyses
software [39]. Clustering of profiles was determined under the
criterion of .80% of band match (Biolmage-Whole Band
Analyzer).
Location of the GEIs within the Hypervariable Regions in
the Strains Chromosome
Six strains with different chromosomal restriction profiles and
with 7 GEIs in their chromosome were selected: strains 12, 58 and
99 from subgroup ‘‘a’’, and strains 124, 127 and 128 from
subgroup ‘‘n’’. The location of the 7 GEIs and of the hypervariable
regions on the chromosome of each strain was carried out by
Southern blot hybridization on the SpeI macrorestriction profile,
using as specific probes the
32P labelled PCR products of the
marker genes of each GEI and from the genes lipA, oprl and pilA for
the detection of each hypervariable region (Megaprime DNA
labeling system, [Amersham Biosciences]). The membranes were
incubated in 10 ml of hybridization solution (Rapid-hyb buffer) to
which 1X Denhardt’s solution and 0.2mg/ml of denatured
sheared salmon sperm were added and incubated at 60uC with
constant and gentle shaking for 3 h. The labeled probe was then
added to fresh hybridization solution and hybridization was
carried out overnight at 60uC with constant and gentle shaking.
After being washed at high astringency (64uC) the membrane was
exposed to a X-ray film. The location of each GEI was deduced
from the comparison of its positive hybridization with the positive
hybridization of each hypervariable region.
Antimicrobial Susceptibility
To assess the susceptibility profiles to 20 antimicrobial agents of
the 100 strains of Pseudomonas aeruginosa isolated from Mexican
adults with pneumonia, the agar dilution method was used
according to the guidelines established by the National Committee
for Clinical Laboratory Standards (NCCLS) [40]. ATCC 27853
Pseudomonas aeruginosa, ATCC 25922 Escherichia coli, ATCC 35218
Escherichia coli, ATCC 29213 Staphylococcus aureus, and ATCC 29212
Enterococcus faecalis were used as controls in the susceptibility tests.
All the strains were grown in Muller Hinton agar and harvested in
sterile saline solution to achieve a turbidity equivalent to that of
a No. 0.5 McFarland opacity standard. The antimicrobial agents
tested against P. aeruginosa were: carbenicillin (16–64 mg/mL),
ticarcillin (8–32 mg/mL), piperacillin (1–8 mg/mL) ticarcillin/
clavulanic acid (8/2–32/2 mg/mL), piperacillin/tazobactam (1/
4–8/4 mg/mL) ceftazidime (1–4 mg/mL) ceftriaxone (8–64 mg/
mL) cefotaxime (8–32 mg/mL) cefepime (1–8 mg/mLl) imipenem
(1–4 mg/mL) meropenem (0.25–1 mg/mlL) aztreonam (2–8 mg/
mL) amikacin (1–4 mg/mL) gentamicin (0.5–2 mg/mL) tobramy-
cin (0.25–1 mg/mL) polymyxin b (0.25–2 mg/mL) ciprofloxacin
(0.25–1 mg/mL) norfloxacin (1–4 mg/mL) and levofloxacin (0.5–
4 mg/mL). Agar dilution was performed using two-fold increments
(across a range of 0.125 to 512 mg/mL) of each antimicrobial
agent incorporated into Muller-Hinton agar. The concentration
range for susceptibility and resistance are indicated in parenthesis
with a MIC value lower than the cut-off to indicate susceptibility
and two-fold dilutions above the cut-off to determine resistance.
The criterion for intermediate susceptibility was based on isolates
growing within one-fold dilution higher than the MIC value.
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Linkage disequilibrium to measure the amount of recombina-
tion within the population sampled was determined using the
standardized index of association IA [41]. The mean genetic
diversity H was calculated using the same software.
Results
Frequency of Virulence Genes
PCR was used to assess the prevalence of eight virulence genes
of which toxA, toxR, algR, lasB, lecA, plcH, and phzA1 were detected
in 100% of the strains, while pilA gene was detected by
hybridization only in 55% of isolates, but its detection increased
to 98% when PCR primers were used to amplify complete pilA
locus. Only two strains were pilA negative.
Frequency of GEIs
The results show that in 99% of the strains at least one genomic
island was present. Of the 100 strains tested, 34% presented all the
GEIs: PAGI-I, PAGI-2, PAGI-3, PAGI-4, PAPI-1 and PAPI-2
and the studied insertion element pKLC102; 18% presented 6
GEIs of which the majority were PAGI-2, PAGI-3, PAGI-4,
PAPI-1, PAPI-2 and pKLC102; 12% strains presented 5 GEIs of
which PAPI-2, PAGI-2, PAPI-1, pKLC102 were always present,
in combination with PAGI-4 or PAGI-3; 14% presented 4 GEIs of
which PAGI-2 and pKLC102 were always detected; 10% of the
isolates presented 3 GEIs, PAPI-2 and pKLC102 in combination
with PAGI-4 or PAGI-2; 7% presented the genomic island PAGI-
2 and pKLC102 element; and 4% of the strains presented only
one GEI. There was only one strain that did not present any GEI.
Finally, the island PAPI-2 and the element pKLC102 were the
most frequently detected among the strains (87%) followed by
PAPI-1 (81%), PAGI-2 (78%), PAGI-4 (70%), PAGI-3 (53%) and
PAGI-1 (51%).
Additionally, the detection of each marker gene of the genomic
islands was variable among strains, showing diversity in their
genetic content. For example, in the detection of PAGI-1,
hybridization was positive for ORF3 in 49 strains, for ORF18 in
43 strains, while ORF42 was positive in 50 strains; 31 strains
showed positive hybridization with two of the three ORFs and less
than half of the strains (20) showed positive hybridization with the
three ORFs (Figure 1). In the detection of PAGI-2, hybridization
of gene C22 was positive in 80 strains and of C105 was positive in
79 strains, with 78 strains being positive for both genes. With
regard to PAGI-3 detection, hybridization was positive with the
probe derived from gene SG8 in 59 strains, while 61 strains were
positive for SG100 and 53 strains for both genes. In the detection
of pKLC102, there was also variability, gene CP10 was positive in
87 strains, CP44 was positive in 88 and CP97 in 70 strains, more
than half of the strains (63) presented all three genes. PAPI-1 was
found to be integrated into the chromosome at locus PA0976.1 in
65% of the isolates, and at locus PA4541.1 in 16% of the isolates.
The circular form of the genomic island was not detected in any of
the strains included in this study.
Macrorrestriction Analysis
According to SpeI fragment patterns, the strains were distributed
in four major clades (A–D), seven clusters (I–VII), and several
individual patterns (Figure 1). Reference strains PAO1, C, and
SG17M were grouped in clade C showing each individual
restriction pattern, while strain PA14 was grouped in clade A. In
terms of genotyping by SpeI fingerprint, we were able to identify 49
genotypes, represented for 49 different restriction pattern of which
35 corresponded to 35 single strains (unique patterns), and the 14
remaining to 14 subgroups (a–n). With respect to the prevalence of
each strain, we found no relationship between the presence of
a strain with a particular chromosomal profile type and its date of
isolation. Each strain appeared in different months, but neither of
them remained present for more than 5 consecutive months nor
through all the period of the study (Figure 2). For example, the
strains of subgroup ‘‘k’’ appeared for the first time in April of 2005
and for last time in March of 2006, although these strains were
only isolated in three different and non-continuous months. The
strains of subgroup ‘‘J’’ appeared in August and were isolated
again in November, 2006. The strains of subgroups ‘‘a’’ and ‘‘g’’
were present during five and four continuous months, respectively
(Figure 2); and only one strain of subgroup ‘‘a’’ was isolated
12 months later. The strains of subgroups ‘‘e’’, ‘‘m’’ and ‘‘n’’ were
detected for a single month without further detection. Although,
each subgroup grouped a determined number of strains with the
same chromosomal profile, the majority of the strains were isolated
from unrelated patients and most of them showed a variable
number of GEIs and/or a different antimicrobial resistance
profiles. Additionally, among the strains with the same number of
GEIs and from the same subgroup differences among the types of
GEIs and/or its marker genes were detected. Finally, the
subgroups ‘‘e’’, ‘‘g’’, ‘‘h’’, ‘‘i’’, ‘‘k’’, ‘‘l’’ and ‘‘m’’ grouped up to
three strains isolated from the same patient at different times, and
although the strains isolated from a same patient presented the
same SpeI fingerprint each of them also had a variable number of
GEIs with different antimicrobial resistance profiles, indicating
that they were unrelated isolates (Figure 1). In this study, the
distribution of P. aeruginosa variants revealed that there was not
a prevalent strain colonizing our patient population.
Location of the GEIs within the Hypervariable Regions in
the Strains Chromosome
The hypervariable regions adjacent to lipH, oprL-phnAB and pilA
loci in the chromosome of the strains of subgroup ‘‘a’’ were located
by southern hybridization in a SpeI restriction map. These regions
hybridized in bands of 131-kb, 287-kb and 335-kb respectively,
and in the strains of subgroup ‘‘n’’ in the bands of 706-kb, 200-kb
and 448-kb respectively (Figure 3). The genomic islands PAGI-3
and PAPI-2, and the element pKLC102 hybridized in the bands
corresponding to the marker genes (lipA, oprL and pilA respectively)
of the hypervariable regions indicating that they are inserted
within the regions reported by the authors. The islands PAGI-2
and PAGI-4 hybridized in bands of different size (Figure 3)
indicating that these islands are in other chromosomal position
different to lipH and oprL-phnAB, for example: the strains 12, 58
and 99 of subgroup ‘‘a’’ were positive in the band of 65-kb for
PAGI-2 and in the bands of 340-kb, 256-kb and 287-kb for PAGI-
4; the strains of subgroup ‘‘n’’ were positive in the band of 275-kb
for PAGI-2 and in the band of 700-kb for PAGI-4. With respect to
the location of PAPI-1, the insertion of this island has been already
detected at the tRNA
Lys gene (PA0976.1) of the hypervariable
region close to oprL-phnAB when we obtained the PCR product
amplified with primers set PAPI -1 and 976F. Finally, the island
PAGI-1 hybridized in the strains of subgroup ‘‘a’’ in two bands of
different size of 284-kb and 205-kb; and in the strains of the
subgroup ‘‘n’’ the island was located in the band of 706-kb size.
Association Index and Genetic Diversity
Statistical analysis of the PFGE data for the 49 genotypes
revealed an association index (IA) value close to 0 (0.0024,
p,0.05), indicating linkage equilibrium and that recombination is
frequent enough to break up clonal formation [41]. However,
when calculated on the basis of all isolates, IA increased to 0.022,
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recombination among members of the population and occasional
emergence of clones that successfully spread and persist for a while
within a limited geographic and temporal span [42]. The mean
genetic diversity H was 0.2749 +/20.0143, which is in accordance
with that found in many human pathogens with narrow ecological
specificity. Others authors have reported a mean genetic diversity
of 0.229 [43] and 0.357 [44] for P. aeruginosa.
Antimicrobial Susceptibility Profile
The determination of susceptibility profiles of 100 isolates to 20
antimicrobial agents showed 34 different resistance profiles, with
100% of strains showing susceptibility to polymyxin B, while the
73% of strains were resistant to 18 antimicrobials in different
combinations. Only 15 strains were susceptible to a wide range of
the antimicrobial tested (from 14 to 18). In general, the multi-
resistance rate among our strains was very high (Figure 4).
Discussion
Bacterial pathogenicity is evoked by the presence of multiple
virulence factors encoded by groups of genes present in the
chromosome and pathogenicity islands that interact in various
combinations [11,12,45,46]. Pseudomonas aeruginosa harbors several
virulence genes used to colonize, destroy, and spread through
tissue. Our results show that all the virulence genes are present in
all strains of the present study and form part of the core genome of
P. aeruginosa. These findings are in agreement with those studies
that suggest that the different virulence genes are harbored by all
P. aeruginosa strains independently from the sites of isolation,
clinical, or environmental sample [14,47].
The genome of a bacterial pathogen is composed of a conserved
‘‘core’’ genome, which contains the genetic information that is
required for essential cellular functions, and a ‘‘flexible’’ gene pool,
or accessory genome, that includes large insertions acquired by
HGT that encode adaptive traits, which may be beneficial for
bacteria under certain growth or environmental conditions. In P.
aeruginosa, extensive genomic rearrangements have been reported,
as well as acquisition or loss of large blocks of DNA contributing to
genome size variations between 5.2 and 7Mb [17,20]. In the P.
aeruginosa chromosome there are three hypervariable regions
[16,17] that reside in the vicinity of the lipH, phnAB and pilA loci,
where tRNA genes has been identified as the hot spots for the
integration and excision of large DNA blocks [15,28,29,31–33]. As
it has been pointed out in previous studies, the insertions of the
majority of the genomic islands take place within a specific region
Figure 1. Unrooted dendrogram for 100 Pseudomonas aeruginosa clinical isolates. The Neighbor-Joining dendrogram was constructed
using PFGE restriction patterns (Spe I) based on a distance generated matrix (Nei’s [1972] Minimum Distance). Upper case letters (A–D) represent the
four generated clades. Clustering of profiles shown in roman numerals was determined under the criterion of .80% of band match (BioImage-Whole
Band Analyzer). Low case letters (a–n) represent strain subgroups. Presence (+) of virulence genes were determined by PCR and presence (+) of GEIs
by hybridization with specific labeled probes. Antibiotic resistance profiles were performed by agar dilution method according to NCCLS. Symbols
beside the strain number indicate isolates from the same patient.
doi:10.1371/journal.pone.0037459.g001
Figure 2. Histogram showing the prevalence of strains genotype (a–n) over time (Apr 05–Nov 06). The genotype of the Pseudomonas
aeruginosa strains was obtained by SpeI macrorestriction fingerprint.
doi:10.1371/journal.pone.0037459.g002
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inserted in any of their hipervariable regions are few, suggesting
that these GEIs are strain-specific and site-specific. However,
contrary to those reports, our results show that one strain can
harbor up to 7 GEIs in its chromosome and the frequency of each
one of them is high in our P. aeruginosa population, suggesting that
the functional competition and site-specific insertion among these
genetic elements is negligible, probably because there are other
sites of insertion in the chromosome that have not been
characterized so far. Although, some authors have reported the
frequency of some GEIs in their P. aeruginosa populations
[33,37,48], there are few studies reporting the presence of several
genomic islands in the chromosome of a single isolate of P.
aeruginosa and unfortunately there are no other epidemiological
data that shows the frequency from up to 7 islands in other P.
aeruginosa populations with which the results from the current study
can be compared.
Analysis of the insertion sites of each genomic island into the
chromosome of the strains of the current study showed that PAGI-
3, PAPI-1 and PAPI-2 and the element pKLC102 were located
each in the hypervariable regions adjacent to lipH, phnAB and pilA
respectively, as have been reported by the authors [15,28,29,31–
33]. We suppose PAPI-1 and PAPI-2 presented a tandem array
located at tRNALys gene PA0976.1 (region pilA) at the same
chromosomal location as in strain PA14. In two strains of
subgroup ‘‘a’’ the genomic island PAGI-1 was located in the same
band of PAPI-2 suggesting that in these strains there could be up
to three genomic islands in the same DNA fragment. However,
this event would not represent any problem, since it is reported
that the island PAGI-1 is not inserted into any tRNA gene, so that
the three islands could coexist without any competition for their
sites of insertion. With respect to the islands PAGI-2 and PAGI-4,
we found that their location in the chromosome is different from
the reported, out of the hypervariable regions adjacent to lipH and
oprL-phnAB respectively, indicating that there are other insertion
sites in chromosome which have not been characterized yet.
Sequencing of these DNA segments will need to be carried out to
determine the specific site of insertion of PAGI-2 and PAGI-4.
In this study, the detection of each genomic island by
hybridization with specific probes on a chromosomal DNA
macroarray were successfully performed, allowing us to work with
a large number of Pseudomonas aeruginosa strains. Additionally, the
marker genes selected were adequate, showing high specificity and
sensitivity for their detection. In a previous work Klockgether and
Figure 3. Location of hypervariable regions and genomic islands on SpeI chromosomal map of two Pseudomonas aeruginosa strains.
(A) Lane 1 shows the chromosomal restriction pattern with SpeI of the strain 12 from subgroup ‘‘a’’. Lane 2 shows the location of the hypervariable
region close to lipH locus obtained for positive hybridization on a band of 130-kb with the marker gene lipA. Lane 3 shows the position of PAGI-3 on
the band of 130-kb of chromosomal restriction pattern. Lane 4 shows the position of PAGI-2 on a band of 65-kb contrary to the expected size of 130-
kb. Lane 5 shows the location of the hypervariable region close to oprL-phnAB loci obtained for positive hybridization on a band of 287-kb with the
marker gene oprL. Lane 6 shows the position of PAPI-2 on the band of 287-kb of chromosomal restriction pattern. Lane 7 shows the position of PAGI-
4 on a band of 340-kb of chromosomal restriction pattern contrary to the expected size of 287-kb. Lane 8 shows the location of the hypervariable
region close to pilA locus obtained for positive hybridization on a band of 335-kb with the marker gene pilA. Lane 9 shows the position of pKLC102
on the band of 335-kb of chromosomal restriction pattern. Lane 10 shows the position of PAGI-1 with a positive hybridization on a band of 284-kb of
chromosomal restriction pattern. (B) Lane 1 shows the chromosomal restriction pattern with SpeI of the strain 127 from subgroup ‘‘n’’. Lane 2 shows
the location of the hypervariable region close to lipH locus obtained for positive hybridization on a band of 317-kb with the marker gene lipA. Lane 3
shows the position of PAGI-3 on the band of 317-kb of chromosomal restriction pattern. Lane 4 shows the position of PAGI-2 on a band of 275-kb of
chromosomal restriction pattern, contrary to the expected size of 317-kb. Lane 5 shows the location of the hypervariable region close to oprL-phnAB
loci obtained for positive hybridization on a band of 200-kb with the marker gene oprL. Lane 6 shows the position of PAPI-2 on a band of
approximately 130-kb of chromosomal restriction pattern. Lane 7 shows the position of PAGI-4 on a band of 700-kb of chromosomal restriction
pattern, contrary to expected size of 200-kb. Lane 8 shows the location of the hypervariable region close to pilA locus obtained on a band of 448-kb
with the marker gene pilA. Lane 9 shows the position of pKLC102 on the band of 448-kb of chromosomal restriction pattern. Lane 10 shows the
position of PAGI-1 on a band of 706-kb of chromosomal restriction pattern.
doi:10.1371/journal.pone.0037459.g003
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characterized in different subtypes according to their hybridization
patterns, showing that these islands were variable in genes content
when compared with the island hybridization patterns from one
strain to another. In the present study, this difference could be seen
in the hybridization patterns with the different marker genes used
for the detection of PAGI-2 and pKLC102. Furthermore, these
differences between the hybridization patterns of the marker genes
were also seen among the islands PAGI-1, PAGI-3 and PAPI-2
suggesting that these islands also present different subtypes.
Little is known about the role of each genomic island in the
virulence and adaptive traits of the bacteria. The majority of the
proteins encoded within these islands have unknown functions
and, in addition, they possess genes that encode functions related
to DNA mobilization, integration, conjugation and partition
activities [15,31]. There are reports that try to associate the
presence of some GEI with a particular pathology. It is known that
PAGI-2 presents gene clusters encoding all nine essential proteins
for the cytochrome c biogenesis system I and related thio-disulfide
exchange protein. The expression of the genes for cytocrhrome c
biogenesis could facilitate iron uptake and inactivation of
peroxides [49], and thus, may confer an advantage for the
bacteria to persist in the CF lung, where they are exposed to iron
limitation and oxidative stress [50,51]. The islands PAPI-1 and
PAPI-2 have been associated in murine acute pneumonia and
bacteremia infection models [52]. PAPI-1 carries several regula-
tory genes, including pvrR, which controls the biofilm formation of
antibiotic resistant variants of P. aeruginosa that are associated with
chronic infections in individuals with cystic fibrosis [15,53–55].
However, to date the involvement of each island in the
development of any particular disease is not clear. The high
frequency of islands PAGI-2, PAPI-1 and PAPI-2 found in the
majority of our strains isolated from lung secretions of patients
with pneumonia, could be explained for their participation in the
development of pneumonia as was pointed in previous studies.
However, what would be the participation of the remaining
islands in this pathology? It is unknown, whether the presence of
several GEIs interact synergistically. Probably the presence of all
GEIs in the P. aeruginosa chromosome is to increase the
pathogenicity of the strain, to favor multidrug resistance and/or
to promote a better adaptation to the hospital and pulmonary
environment. We do not know which is the frequency of these
islands in strains isolated from other pathologies (urinary tract
infection or septicemia), or in strains isolated from the natural
environment in Mexico, but we know that the strains isolated from
patients with pneumonia present a high frequency of GEIs.
The complete genetic and phenotypic characterization of 100
strains of P. aeruginosa associated with pneumonia infection in
patients admitted to the intensive care unit of a highly specialized
hospital in Mexico, showed that the infections were caused by
unrelated strains with a great genomic diversity and that there was
no cross-infection between patients associated with a single clone.
The results support the idea that P. aeruginosa exhibits an epidemic
population structure, which is predominantly sexual with the
occasional emergence of clones that are only distributed and
Figure 4. Histogram showing antimicrobial susceptibility profile of 100 Pseudomonas aeruginosa clinical strains to 20 common
antimicrobials.
doi:10.1371/journal.pone.0037459.g004
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hospital environment.
We speculated that the high incidence of GEIs present in the
collection of studied strains could be associated with multidrug-
resistance present in these strains and the type of patients
(hospitalized in ICU) from which the strains were isolated.
However, this hypothesis cannot be proven yet since strains of P.
aeruginosa isolated from other sources with low antimicrobial
resistance profiles need to be studied.
Final Conclusions
We can say that the high frequency of GEIs detection in P.
aeruginosa strains in our population suggested: first, GEIs are not
specific of strains and some are inserted elsewhere within
chromosome in uncharacterized sites yet; second, the horizontal
transfer of genes among our strains is common, leading to high
contents of GEIs; and third, our strains are different to the strains
and clones circulating in other parts of the world.
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